AI assistant
Innoviva, Inc. — Director's Dealing 2013
Jun 12, 2013
32090_dirs_2013-06-11_652426c0-1ff8-4b6f-a31e-ae26088c802c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2013-06-07
Reporting Person: Shafer Bradford J (Sr VP, Gen. Counsel, Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-07 | Common Stock | S | 31038 | $35.04 | Disposed | 303416 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2750 | Indirect |
| Common Stock | 2750 | Indirect |
| Common Stock | 2750 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $34.99 to $35.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2: Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.